Answers are grounded in this paper and cite their sources.
Integrins are transmembrane receptors that, as critical participants in a vast range of pathological processes, are potential therapeutic targets. However, in only a few cases has the promise been realized by drug approval. In this review, we briefly review basic integrin biology and participation in disease, challenges in the development of safe, effective integrin-targeted therapies, and recent advances that may lead to progress.
No takes yet. Share an insight, caveat, or question.
Meredith et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: